Pharmaceutical Business Review
Anonymous User | Login

BioSante Pharmaceuticals Files NDA For Elestrin In Israel

Published: 23-Jun-2009

Elestrin to be used for the treatment of vasomotor symptoms associated with menopause

PharmaSwiss, Israeli licensee of BioSante Pharmaceuticals, has submitted a new drug application (NDA) for Elestrin in Israel.

The Elestrin filing is based on BioSante’ FDA approved NDA for the treatment of moderate-to-severe vasomotor symptoms (hot flashes), associated with menopause. According to the agreement, PharmaSwiss is responsible for regulatory and marketing activities in Israel.

Stephen Simes, President and CEO, BioSante Pharmaceuticals, said: “We believe PharmaSwiss is in an excellent position to capture an important share of the Israeli estrogen therapy market once Elestrin is approved. We look forward to working with PharmaSwiss on the successful marketing of Elestrin in Israel, and expanding the distribution of Elestrin beyond the US.”

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Solutions4Science

Temperature Mapping and Validation Services ...

Exploristics

Innovative Analysis Solutions for Data Exploration, Pharmacogenetics, Biomarkers and Exploratory Sta...

NeuroProof

Screening Services for Pre-Clinical Development of Neuro-Pharmaceuticals and Safety Pharmacology ...

DASGIP

Parallel Bioreactor Systems for the Cultivation of Bacterial, Phototrophic, Animal and Human Cells ...

BioKinetic Europe

Phase I/II Contract Research Organisation ...

Toxikon Europe

CRO Providing Preclinical Safety Studies for the Life Science Community ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

GRACO's New FDA Pumps

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

GRACO's New Hydra-Clean

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

GRACO's New 1590 & 3150 Pumps

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

Customer Testimonial – Astra Zeneca

From the control room to the downstream processing area and with an eye on utilities servi ...

Hygienic Processing

From the control room to the downstream processing area and with an eye on utilities servi ...

Related Companies

Noven Pharmaceuticals, Inc.

Noven Pharmaceuticals, Inc. (Noven) is a specialty pharmaceutical company engaged in t ...

Auxilium Pharmaceuticals, Inc.

Auxilium Pharmaceuticals, Inc. (Auxilium) is a specialty biopharmaceutical company focu ...

Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals (Watson) is a specialty pharmaceutical company engaged in the de ...

BioSante Pharmaceuticals, Inc.

BioSante Pharmaceuticals, Inc. (BioSante) is focused on developing products for female ...

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address